Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Finished Goods (2022 - 2025)

Historic Finished Goods for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $165000.0.

  • Envoy Medical's Finished Goods rose 2692.31% to $165000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $165000.0, marking a year-over-year increase of 2692.31%. This contributed to the annual value of $119000.0 for FY2024, which is 4166.67% up from last year.
  • Latest data reveals that Envoy Medical reported Finished Goods of $165000.0 as of Q3 2025, which was up 2692.31% from $120000.0 recorded in Q2 2025.
  • Envoy Medical's Finished Goods' 5-year high stood at $165000.0 during Q3 2025, with a 5-year trough of $84000.0 in Q4 2023.
  • Moreover, its 4-year median value for Finished Goods was $120500.0 (2022), whereas its average is $123200.0.
  • In the last 5 years, Envoy Medical's Finished Goods crashed by 3057.85% in 2023 and then skyrocketed by 5471.7% in 2025.
  • Over the past 4 years, Envoy Medical's Finished Goods (Quarter) stood at $121000.0 in 2022, then tumbled by 30.58% to $84000.0 in 2023, then skyrocketed by 41.67% to $119000.0 in 2024, then surged by 38.66% to $165000.0 in 2025.
  • Its Finished Goods was $165000.0 in Q3 2025, compared to $120000.0 in Q2 2025 and $164000.0 in Q1 2025.